Balugrastim

DB12699InvestigationalProtein Based Therapies

Balugrastim has been used in trials studying the treatment of Solid Tumors.

Mechanism: Pharmacologically active on Granulocyte colony-stimulating factor receptor
Curator reviewed

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 17 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Balugrastim, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.